Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes
<p>Abstract</p> <p>Background</p> <p>To explore the concept of the Minimum Clinically Important Difference (MID) of the Worry Scale of the Hypoglycaemia Fear Survey (HFS-II) and to quantify the clinical importance of different types of patient-reported hypoglycaemia.<...
Main Authors: | Gonder-Frederick Linda, Stargardt Tom, Krobot Karl J, Alexander Charles M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-10-01
|
Series: | Health and Quality of Life Outcomes |
Online Access: | http://www.hqlo.com/content/7/1/91 |
Similar Items
-
Fear of hypoglycaemia in patients with type 1 diabetes
by: Evgenia Mikhailovna Patrakeeva, et al.
Published: (2014-07-01) -
Fear of hypoglycaemia and self-management in type 1 diabetes
by: Aila J. Ahola, et al.
Published: (2016-06-01) -
Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review
by: Noyes Kathryn, et al.
Published: (2010-07-01) -
A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc)
by: Stephanie A. Amiel, et al.
Published: (2022-04-01) -
Effect of fear of hypoglycaemia on sleep quality of patients with type 2 mellitus diabetes: The mediating role of alexithymia
by: Liuhong Tian, et al.
Published: (2024-02-01)